TLR2 Gene - Toll Like Receptor 2
Key innate immune receptor for pathogen recognition and signaling
Gene Information Card
| Symbol | TLR2 |
|---|---|
| Full Name | Toll Like Receptor 2 |
| Gene Type | protein-coding |
| Chromosomal Location | 4q31.3 |
| NCBI Gene ID | 7097 ncbi.nlm.nih.gov/gene/7097 |
| Ensembl ID | ENSG00000137462 |
| UniProt ID | O60603 |
| OMIM ID | 603028 |
| HGNC ID | 11849 |
| Aliases | CD282, TIL4 |
Description
TLR2 (Toll Like Receptor 2) is a member of the Toll-like receptor (TLR) family, which plays a fundamental role in pathogen recognition and activation of innate immunity. TLR2 recognizes a wide variety of microbial components, including lipoproteins, peptidoglycan, and lipoteichoic acid from Gram-positive bacteria, as well as zymosan from fungi. It forms heterodimers with TLR1 or TLR6 to discriminate between different ligands. Upon ligand binding, TLR2 activates NF-κB and MAPK signaling pathways, leading to cytokine production and inflammatory responses. TLR2 is expressed on the surface of immune cells such as macrophages, dendritic cells, and neutrophils, and also on non-immune cells like epithelial and endothelial cells. Genetic variations in TLR2 have been associated with increased susceptibility to infections, sepsis, and inflammatory diseases.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Leprosy (tuberculoid type) | TLR2 polymorphisms impair recognition of M. leprae lipoproteins, reducing Th1 response | PMID: 12692541 |
| Sepsis | TLR2 mutations (e.g., R753Q) lead to hyporesponsiveness to Gram-positive bacterial components, increasing infection risk | PMID: 10917503 |
| Atherosclerosis | TLR2 activation by microbial ligands promotes vascular inflammation and plaque formation | PMID: 15528464 |
| Asthma | TLR2 variants influence airway inflammation and susceptibility to asthma exacerbations | PMID: 15128703 |
| Lyme disease | TLR2 deficiency impairs recognition of Borrelia burgdorferi lipoproteins, affecting immune clearance | PMID: 11894097 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Lung | 12.5 | Medium |
| Spleen | 10.8 | Medium |
| Whole blood | 8.9 | Medium |
| Bone marrow | 7.6 | Medium |
| Liver | 4.2 | Low |
| Small intestine | 3.5 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| THP-1 (monocyte) | 15.2 | High expression |
| U937 (macrophage) | 12.8 | High expression |
| HeLa (epithelial) | 2.1 | Low expression |
| HepG2 (hepatocyte) | 1.5 | Very low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| R753Q | Missense | 0.5-2% in European populations | Reduced TLR2 signaling in response to Gram-positive bacteria |
| P631H | Missense | <0.1% | Impaired ligand recognition and NF-κB activation |
| R677W | Missense | Rare | Associated with lepromatous leprosy |
| G2258A (3'UTR) | Regulatory | Common (allele frequency ~10%) | Reduced TLR2 expression and increased sepsis risk |
Mutation functional classification
Loss of Function (LOF)
R753Q and P631H reduce or abolish TLR2-mediated NF-κB activation and cytokine production upon ligand stimulation.
Gain of Function (GOF)
No well-characterized gain-of-function mutations reported in TLR2.
Dominant Negative (DN)
R753Q may act in a dominant-negative manner by forming non-functional heterodimers with wild-type TLR2.
View complete mutation data:
Gene Ontology (GO)
| • GO:0004888 - transmembrane signaling receptor activity | • GO:0007165 - signal transduction |
| • GO:0006954 - inflammatory response | • GO:0045087 - innate immune response |
| • GO:0002224 - toll-like receptor signaling pathway | • GO:0005886 - plasma membrane |
| • GO:0035662 - Toll-like receptor 2 binding |
Pathways
• Toll-like receptor signaling pathway (KEGG: hsa04620)
• NF-kappa B signaling pathway (KEGG: hsa04064)
• MyD88-dependent cascade (Reactome: R-HSA-166058)
• Innate Immune System (Reactome: R-HSA-168249)
Protein Summary
TLR2 is a 784-amino acid type I transmembrane protein with an extracellular leucine-rich repeat (LRR) domain and a cytoplasmic Toll/IL-1 receptor (TIR) domain. The LRR domain mediates recognition of pathogen-associated molecular patterns (PAMPs), while the TIR domain recruits adaptor proteins such as MyD88 to initiate downstream signaling. TLR2 forms functional heterodimers with TLR1 or TLR6, enabling recognition of triacylated and diacylated lipoproteins, respectively. The protein is heavily glycosylated and localized primarily to the plasma membrane, though it can also be found in endosomes. TLR2 signaling is critical for host defense against bacteria, fungi, and viruses, and its dysregulation contributes to chronic inflammatory and autoimmune diseases.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TLR2 Knockout HEK293 Cell Line | EDJ-KQ17909 | Human | 7097 | Details Get a Quote |
| TLR2 Knockout A-549 Cell Line | EDC90495 | Human | 7097 | Details Get a Quote |
| TLR2 Knockout THP-1 Cell Line | EDJ-KZ51 | Human | 7097 | Details Get a Quote |
| TLR2 Knockout HeLa Cell Line | EDJ-KQ54666 | Human | 7097 | Details Get a Quote |
| TLR2 Knockout HCT 116 Cell Line | EDJ-KQ71622 | Human | 7097 | Details Get a Quote |
| Tlr2 Knockout RAW 264.7 Cell Line | EDJ-KQ78092 | Mouse | 24088 | Details Get a Quote |
Displaying Records 1 To 6 Of 6 Records